IP Library Granted Patent US 8,002,965
Granted Patent B2
US 8,002,965 · App. 11/887,879 · Granted Aug 23, 2011

Oxidizable species as an internal reference in control solutions for biosensors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,002,965
App. No.
11/887,879
Granted
Aug 23, 2011
Kind
B2
Abstract

Testing of the performance of an electrochemical meter used to measure the presence of an analyte in a biological sample, particularly glucose in whole blood, includes introducing a control solution containing a predetermined amount of the analyte and a predetermined amount of an internal reference compound. The internal reference compound is selected such that it is oxidized at a potential greater than that used to oxidize the analyte, thereby making it possible to distinguish the control solution from a biological sample.

Claims (35)

1. A method of distinguishing a control solution from a sample during operation of an electrochemical sensor measuring the amount of an analyte in said control solution and in said sample, the method comprising the acts of:

(a) adding to said control solution an internal reference compound, said compound being adapted to be electrochemically oxidized at a potential higher than the potential needed to measure the oxidation of said analyte;

(b) introducing said control solution containing said internal reference compound and a predetermined amount of said analyte to said electrochemical sensor, said sensor having working and counter electrodes and a reagent;

(c) at least once applying a potential to said electrochemical sensor sufficient to oxidize said internal reference compound and said analyte, and measuring the resulting electrical current;

(d) at least once applying a potential to said electrochemical sensor lower than the potential of (c), said potential being sufficient to measure oxidation of said analyte and not sufficient to oxidize said internal reference compound, and measuring the resulting electrical current;

(e) calculating a Differential Index (DI) defined as DI=i high volt /i low volt

where:

i high volt is the current measured in (c)

i low volt is the current measured in (d)

(f) determining that a control solution is present when the Differential Index of (e) is sufficiently greater than 1 to distinguish said internal reference compound from said predetermined amount of analyte; and

(g) determining that a sample is present when the Differential Index of (e) is about 1; wherein the potential of (d) is applied before the potential of (c).

2. The method of claim 1 , wherein said Differential Index determined in (f) is 1.5 or higher.

3. The method of claim 1 , wherein said analyte is glucose and said sample is whole blood.

4. The method of claim 1 , wherein said internal reference compound is added in an amount proportional to the amount of the analyte present in said control solution.

5. The method of claim 4 , wherein said internal reference compound is added in an amount such that the Differential Index is 1.5 or higher when the amount of the analyte is the maximum used in said control solution.

6. The method of claim 1 , wherein said internal reference compound is an oxidizable organo-metallic compound, coordination compound, or organic amine compound.

7. The method of claim 6 , wherein said internal reference compound is said organic amine compound, said organic amine compound being 3-(N-morpholino) propane sulfonic acid, N-(2-hydroxyethyl)piperazine-N 1 -(2-ethane sulfonic acid), 2-[(2-Hydroxy-1,1-bis(hydroxy methyl)ethylamino]ethane sulfonic acid, 2-Morpholino ethane sulfonic acid, and Bis(2-hydroxyethyl)amino-tris (hydroxymethyl)methane[Bis-Tris], 4-aminobenzonitrile, 4-aminobenzoic acid, or 4-iodoaniline.

8. The method of claim 6 , wherein said internal reference compound is said oxidizable organo-metallic compound, said oxidizable organo-metallic compound being ferrocene or ferrocene derivatives.

9. The method of claim 6 , wherein said internal reference compound is said coordination compound, said coordination compound being potassium ferrocyanide.

10. A method of distinguishing a control solution from a sample during operation of an electrochemical sensor, the electrochemical sensor measuring the amount of an analyte, the method comprising the acts of:

providing a control solution including an internal reference compound, a buffer and a predetermined amount of analyte, said internal reference compound having a higher potential than the potential needed to measure the oxidation of said analyte, said internal reference compound being different from said buffer;

providing an electrochemical sensor having a working electrode and a counter electrode;

introducing said control solution to the electrochemical sensor;

applying a first potential to said electrochemical sensor, said lower first potential being sufficient to oxidize said analyte and not sufficient to oxidize said internal reference compound, and measuring the resulting electrical current;

after applying the first potential, applying a second potential to said electrochemical sensor sufficient to oxidize said internal reference compound and said analyte, and measuring the resulting electrical current;

calculating a Differential Index DI defined as DI=i high volt /i low volt

where:

i high volt is the current measured after applying the second potential, and i low volt is the current measured after applying the first potential;

if the Differential Index is sufficiently greater than 1, determining that a control solution is present; and

if the Differential Index is about 1, determining that a sample is present.

11. The method of claim 10 , wherein said analyte is glucose and said biological sample is whole blood.

12. The method of claim 10 , wherein said internal reference compound is an oxidizable organo-metallic compound, coordination compound, or organic amine compound.

13. The method of claim 12 , wherein said internal reference compound is said organic amine compound, said organic amine compound being 3-(N-morpholino) propane sulfonic acid, N-(2-hydroxyethyl)piperazine-N 1 -(2-ethane sulfonic acid), 2-[(2-Hydroxy-1,1-bis(hydroxy methyl)ethylamino]ethane sulfonic acid, 2-Morpholino ethane sulfonic acid, and Bis(2-hydroxyethyl)amino-tris (hydroxymethyl)methane[Bis-Tris], 4-aminobenzonitrile, 4-aminobenzoic acid, or 4-iodoaniline.

14. The method of claim 12 , wherein said internal reference compound is said oxidizable organo-metallic compound, said oxidizable organo-metallic compound being ferrocene or ferrocene derivatives.

15. The method of claim 12 , wherein said internal reference compound is said coordination compound, said coordination compound being potassium ferrocyanide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2016
From: BAYER HEALTHCARE LLC
To: ASCENSIA DIABETES CARE HOLDINGS AG
Reel/Frame 037880/0604 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2007
From: BEER, GREG; WU, HUAN-PING
To: BAYER HEALTHCARE LLC
Reel/Frame 019979/0004 →